喵ID:eNvETi免责声明

18F-DCFPyL的制备和初步临床应用

基本信息

DOI:
--
发表时间:
2018
期刊:
同位素
影响因子:
--
通讯作者:
张锦明
中科院分区:
其他
文献类型:
--
作者: 张晓军;付华平;李云钢;刘健;何玉林;刘亚超;徐白萱;朱虹;吴江;崔孟超;张锦明研究方向: -- MeSH主题词: --
关键词: --
来源链接:pubmed详情页地址

文献摘要

Automatically synthesize the prostate-specific membrane antigen (PSMA) imaging agent 18F-DCFPyL (2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridin-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid) using a domestic fluorine multi-functional module and conduct biological evaluations. By changing different hydrolysis conditions, study the hydrolysis efficiency of the fluorinated intermediate, conduct quality control and biosafety evaluation on 18F-DCFPyL, and explore the biological properties of 18F-DCFPyL through the biological distribution in mice and preliminary clinical trials. A patient with biochemical recurrence after prostate cancer surgery underwent 18F-DCFPyL PET/CT imaging. The results showed that the hydrolysis efficiencies of three acids, H3PO4, HCl, and HI, were similar, being 17.1%, 16.9%, and 18.4% respectively. The radiochemical purity of the obtained product was greater than 98%, and the specific activity was 54 - 90 GBq/μmol. 18F-DCFPyL was excreted through the urinary system in mice, and there was no significant uptake in other tissues. In a patient with biochemical recurrence after prostate cancer surgery, 18F-DCFPyL PET imaging could detect small metastatic lesions that could not be detected by CT on the same machine. The domestic fluorine multi-functional module has high stability and repeatability in the automatic synthesis of 18F-DCFPyL, and the product quality meets the requirements of clinical research. 18F-DCFPyL has good biological distribution characteristics and can be used for the early diagnosis of prostate cancer and the detection of lesions in patients with biochemical recurrence of prostate cancer.
:利用国产氟多功能模块自动化合成前列腺特异性膜抗原(PSMA)显像剂18F-DCFPyL(2-(3-{1-羧基-5-[(6-[18F]氟-吡啶-3-羰基)-胺基]-戊基}-脲基)-戊二酸)并进行生物学评价。通过改变不同的水解条件,研究氟化中间体的水解效率,对18F-DCFPyL进行质量控制和生物安全性评价,并通过小鼠生物学分布和初步临床试验探讨18F-DCFPyL的生物学性质,一例生化复发的前列腺癌术后患者进行了18FDCFPyL PET/CT显像。结果表明,H3PO4、HCl和HI三种酸的水解效率相近,分别为17.1%、16.9%和18.4%,得到产品放化纯度均大于98%,比活度为54~90GBq/μmol,18F-DCFPyL在小鼠体内经泌尿系统排泄,其余组织无明显摄取,前列腺癌术后生化复发的患者18F-DCFPyL PET显像能够探查同机CT无法检出的微小转移灶。国产氟多功能模块自动化合成18F-DCFPyL的稳定性和重复性高,产品质量符合临床研究要求,18F-DCFPyL具有良好的生物学分布特性,可用于早期诊断前列腺癌及探测前列腺癌生化复发患者的病灶。
参考文献(0)
被引文献(0)

数据更新时间:{{ references.updateTime }}

关联基金

前列腺癌早期诊断的PET/MR多模态分子影像研究
批准号:
81571715
批准年份:
2015
资助金额:
57.0
项目类别:
面上项目
张锦明
通讯地址:
--
所属机构:
--
电子邮件地址:
--
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓